These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 15117734

  • 21. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.
    Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC.
    Hum Mol Genet; 2002 Nov 15; 11(24):3031-8. PubMed ID: 12417524
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
    Grosskopf I, Baroukh N, Lee SJ, Kamari Y, Harats D, Rubin EM, Pennacchio LA, Cooper AD.
    Arterioscler Thromb Vasc Biol; 2005 Dec 15; 25(12):2573-9. PubMed ID: 16166565
    [Abstract] [Full Text] [Related]

  • 28. Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients.
    Pruneta-Deloche V, Ponsin G, Groisne L, Fruchart-Najib J, Lagarde M, Moulin P.
    Atherosclerosis; 2005 Aug 15; 181(2):403-5. PubMed ID: 16039297
    [Abstract] [Full Text] [Related]

  • 29. Give me A5 for lipoprotein hydrolysis!
    Merkel M, Heeren J.
    J Clin Invest; 2005 Oct 15; 115(10):2694-6. PubMed ID: 16200205
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.
    Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL.
    Science; 1990 Aug 17; 249(4970):790-3. PubMed ID: 2167514
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction.
    Hubacek JA, Skodová Z, Adámková V, Lánská V, Poledne R.
    Clin Genet; 2004 Feb 17; 65(2):126-30. PubMed ID: 14984471
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.
    Vaessen SF, Dallinga-Thie GM, Ross CJ, Splint LJ, Castellani LW, Rensen PC, Hayden MR, Schaap FG, Kuivenhoven JA.
    J Lipid Res; 2009 May 17; 50(5):880-4. PubMed ID: 19141870
    [Abstract] [Full Text] [Related]

  • 37. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
    Henneman P, Schaap FG, Havekes LM, Rensen PC, Frants RR, van Tol A, Hattori H, Smelt AH, van Dijk KW.
    Atherosclerosis; 2007 Jul 17; 193(1):129-34. PubMed ID: 16777114
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.
    Shachter NS, Hayek T, Leff T, Smith JD, Rosenberg DW, Walsh A, Ramakrishnan R, Goldberg IJ, Ginsberg HN, Breslow JL.
    J Clin Invest; 1994 Apr 17; 93(4):1683-90. PubMed ID: 8163669
    [Abstract] [Full Text] [Related]

  • 39. Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
    Chang CK, Lin XR, Lin YL, Fang WH, Lin SW, Chang SY, Kao JT.
    PLoS One; 2018 Apr 17; 13(2):e0192740. PubMed ID: 29425239
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.